BioNxt Solutions Provides Bi-weekly MCTO Status Report

May 29, 2025 7:00 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), announces that, further to its news release dated May 1, 2025 (the "Default Announcement"), the Company's principal regulator, the British Columbia Securities Commission (the "BCSC") granted a management cease trade order (the "MCTO") on May 1, 2025, under National Policy 12-203 Management Cease Trade Orders ("NP 12-203").Pursuant to the MCTO, the Chief...

Read more

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

May 29, 2025 4:05 PM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, is rescheduling its intra-quarter webcast and investor update call to June 17, 2025, from June 3, 2025, to allow for the implementation of a reverse stock split that will become effective on June 2, 2025.Prepared remarks by members of the Applied DNA management team will be followed by a live...

Read more

DrSkin Med Spa Wins Best Med Spa 2025 in Gilbert - Earns Triple Recognition Across Categories

May 29, 2025 1:00 PM

DrSkin Plastic Surgery, Regenerative & Medical Spa, Arizona's destination for plastic surgery and integrative aesthetic medicine, is proud to announce it has been voted Best Med Spa 2025 in the annual Best of Gilbert competition hosted by the Gilbert Sun News. In addition to earning the Top Spot in the Med Spa category, DrSkin Med Spa was also Reader Recommended in Best Skin Care and Best Plastic Surgery - making it the only practice recognized...

Read more

World Digestive Health Day: Bactose, A New Probiotic Breakthrough Tackles Lactose Digestion Issues Disproportionately Affecting Communities of Color

May 29, 2025 12:30 PM

On World Digestive Health Day, May 29, Bactose is calling attention to a health issue that affects millions - especially in communities of color - and offering a new way forward. Lactose intolerance affects over 36 million people in the United States, with the highest rates found in Black, Asian, Latino, and Indigenous populations. For decades, the standard advice has been to avoid dairy, rely on inconvenient fixes like lactase enzyme tablets...

Read more

See Life Better Foundation Launches Inaugural "Saddle Up for Sight" Fundraiser to Support Sight-Restoring Surgeries

May 29, 2025 12:00 PM

The See Life Better Foundation, founded by Dr. Michael Mann, is a nonprofit organization dedicated to restoring vision for individuals who cannot afford the care they need. Whether through international mission trips to underserved countries or providing sight-restoring surgeries at Mann Eye Institute in Texas, their belief is simple: everyone deserves the right to sight, regardless of financial standing.This past weekend, the See Life Better...

Read more

Mitolyn Side Effects and Complaints Investigated: 2025 User Reviews Tested & Verified

May 29, 2025 10:00 AM

Mitolyn has quickly become one of the hottest weight loss supplements in 2025. If you're like me, you've probably seen it all over social media, Reddit, and YouTube. When I first looked into it, I was curious but skeptical, so I dug deep into the full Mitolyn safety report before deciding if it was worth trying.In this review, I'll cover what's really inside Mitolyn, how it works, what real users say, and the risks of fake reviews and...

Read more

Elevate X Powers the $600B Longevity Economy With AI-Driven, White-Labeled Clinical Infrastructure

May 29, 2025 10:00 AM

Elevate X, a new clinical infrastructure platform purpose-built for the longevity economy, today announces the launch of its early access program to enable wellness brands, creators, and clinicians to deliver physician-grade health programs-without the burden of building their own clinical operations.Founded by Stanford-trained physician and serial healthtech founder Dr. Hillary Lin, Elevate X provides the full-stack engine to power precision...

Read more

1upHealth Launches Prior Authorization Solution and Technology Partnerships to Support CMS Electronic Prior Authorization Mandate for Health Plans

May 29, 2025 9:03 AM

1upHealth, a leader in health data interoperability, today announced the launch of its 1up Prior Authorization solution. The solution is designed to ensure compliance with the CMS Interoperability and Prior Authorization final rule (CMS-0057) while delivering measurable ROI through reduced provider burden and lower administrative costs for payers. To accelerate adoption of electronic Prior Authorization (ePA), 1upHealth is also building...

Read more

The Ridge RTC Launches Emerging Adult Program for 18-20 Year Olds at New Hampshire Campus

May 29, 2025 9:00 AM

The Ridge RTC, a national leader in adolescent residential mental health care, has announced the launch of a new program dedicated to the mental health needs of emerging adults. The Emerging Adult Residential Treatment Program will provide individuals aged 18 to 20 with targeted mental health support and a better alternative to adult programs at The Ridge New Hampshire campus.Currently, The Ridge is one of just a few residential treatment...

Read more

Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer

May 29, 2025 9:00 AM

Ludwig Enterprises (LUDG) today announced the publication of an abstract on the American Society of Clinical Oncology (ASCO) website in connection with the ASCO 2025 Annual Meeting, previously under embargo, detailing a novel, non-invasive scanning test for breast cancer. The research combines the analysis of messenger RNA (mRNA) from non-invasively collected buccal (cheek) cells with machine learning algorithms.The abstract, titled...

Read more

Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints

May 29, 2025 8:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced compelling preclinical results from a study evaluating its novel oral therapeutic, Telomir-1, in a genetically modified zebrafish model of age-related macular degeneration (AMD). Following a 14-day oral dosing regimen, Telomir-1 reversed central vision response and vision acuity, restored retinal degeneration and...

Read more

Burnjaro Reviews and Complaints (Honest Report) Burn Jaro inspired by Slimjaro Pink Salt Trick

May 29, 2025 8:25 AM

NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / In a world that increasingly values health, appearance, and performance, finding the right weight-loss solution has never been more crucial-or more confusing. With shelves overflowing with pills, powders, and drinks that promise to torch fat and boost metabolism, standing out in this crowded industry is no small feat. And yet, BurnJaro has managed to do just that. BurnJaro: The Ultimate Guide...

Read more

Yunu Unveils Next-Gen Trial Imaging with New eCRF Builder, Custom Dashboards & Universal Integration Portal

May 29, 2025 8:15 AM

Yunu, the creator and leader in cloud-native imaging workflows for clinical trials, today announced a major new software release that empowers pharma sponsors to configure studies in minutes, enforce consistency, and deliver imaging data straight into their primary data systems - while simplifying work for site staff.Yunu's unified cloud-SaaS platform powers end-to-end imaging workflows for thousands of clinical trials worldwide. From...

Read more

Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%

May 29, 2025 8:00 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"), a leader in AI-powered scent digitization, announced today that its proprietary AI Nose platform achieved approximately 85% accuracy in detecting excretion odors data, an improvement from 80% previously, based on collected from 254 participant instances in Japan and Taiwan, resulting in 2119 valid entries for subsequent statistical evaluation. The milestone validates AI Nose as a deploy able...

Read more

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

May 29, 2025 8:00 AM

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding common stock. The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on June 2, 2025, and Applied DNA common stock will begin trading on a split-adjusted basis on The Nasdaq Capital Market (the "Nasdaq") as of the...

Read more

Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes

May 29, 2025 7:45 AM

Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare infrastructure company transforming the prescription drug ecosystem, today announced its preliminary inclusion in the Russell 2000 and Russell 3000 Indexes, as part of the 2025 Russell US Indexes annual reconstitution. FTSE Russell released the preliminary list of additions and deletions to the Russell 2000 and Russell 3000 Indexes on Friday, May 23, with final inclusion expected to take...

Read more

Quasar Medical to Acquire Nordson MEDICAL Design and Development Business in Galway, Ireland, and Tecate, Mexico

May 29, 2025 7:30 AM

Quasar Medical, a global leader in the manufacturing of interventional and complex minimally invasive devices, announced it has signed a definitive agreement with Nordson Corporation (NASDAQ:NDSN) to acquire its design and development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. This will strengthen Quasar's global position as a full-service Contract Development and Manufacturing Organization (CDMO), offering...

Read more

Quasar Medical Will Acquire Nordson MEDICAL Design and Development Business in Galway, Ireland, and Tecate, Mexico

May 29, 2025 7:30 AM

Quasar Medical, a global leader in the manufacturing of interventional and complex minimally invasive devices, announced it has signed a definitive agreement with Nordson Corporation (NASDAQ:NDSN) to acquire its design and development contract manufacturing businesses in Galway, Ireland, and Tecate, Mexico. This will strengthen Quasar's global position as a full-service Contract Development and Manufacturing Organization (CDMO), offering...

Read more

Moderna Announces Update on Investigational Pandemic Influenza Program

May 28, 2025 6:00 PM

Moderna, Inc. (NASDAQ:MRNA) today announced positive interim data from a Phase 1/2 clinical study (NCT05972174) evaluating the safety and immunogenicity of its investigational pandemic influenza vaccine, mRNA-1018, in approximately 300 healthy adults aged 18 years and older. The interim results focus on a vaccine candidate targeting the H5 avian influenza virus subtype.The Company had previously expected to advance the program to late-stage...

Read more

The National Children's Cancer Society (NCCS) Celebrates 20 Years of the Beyond the Cure Survivorship Program

May 28, 2025 5:00 PM

This year marks a major milestone for The National Children's Cancer Society (NCCS) as we celebrate the 20th anniversary of our Beyond the Cure Survivorship Program. Since its founding in 2005, this program has remained at the forefront of survivorship care, providing childhood cancer survivors and their families with essential education, resources, and long-term support to help their children not just survive-but thrive.The idea for the program...

Read more